Serum D-asparagine concentration adjusted for eGFR could serve as a novel screening tool for urothelial carcinoma
Biochemical and Biophysical Research Communications · 2024
DOI: 10.1016/j.bbrc.2024.150701 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Akinaru Yamamoto und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan. Hauptthemen laut MEDLINE: Asparagine, Glomerular Filtration Rate. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Takeda Medical Research Foundation, Takeda Science Foundation, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
The sensitivity of currently available screening tools for urothelial carcinoma (UC) remains unsatisfactory particularly at early stages. Hence, we aimed to establish a novel blood-based screening tool for urothelial carcinoma. We measured serum d-amino acid levels in 108 and 192 patients with and without UC individuals in the derivation cohort, and 15 and 25 patients with and without UC in the validation cohort. Serum d-asparagine levels were significantly higher in patients with UC than in those without UC (p < 0.0001). We developed a novel screening equation for the diagnosis of urothelial carcinoma using d-asparagine in serum and estimated the glomerular filtration rate (eGFR). Serum d-asparagine levels adjusted for eGFR exhibited high performance in the diagnosis of UC (AUC-ROC, 0.869; sensitivity, 80.6 %; specificity, 82.7 %), even in early-stage UC (AUC-ROC: 0.859, sensitivity: 83.3 %, specificity: 82.3 %), which were previously misdiagnosed via urinary occult blood or urine cytology. This established strategy combined with urinary occult blood, improves diagnostic ability (sensitivity: 93.7 %, specificity: 70.1 %).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan.
- Department of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan. Electronic address: kawashima@uro.med.osaka-u.ac.jp.
- Department of Nephrology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan.
- KAGAMI Inc., Ibaraki, Osaka, 567-0082, Japan.
- Department of Urology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, 852-8501, Japan.
- Kansai Medical Clinic for Renal Transplantation, Toyonaka, Osaka, 560-0083, Japan.
Förderung
- Takeda Medical Research Foundation
- Takeda Science Foundation
- Japan Society for the Promotion of Science
Zitieren
APA
Yamamoto, A., Kawashima, A., Sakai, S., Mita, M., Sassi, N., Inoguchi, S., Horibe, Y., Yoshimura, A., Tani, M., Yutong, L., Okuda, Y., Oka, T., Uemura, T., Yamamichi, G., Ishizuya, Y., Hayashi, T., Yamamoto, Y., Kato, T., Hatano, K., …, & Nonomura, N. (2024). Serum D-asparagine concentration adjusted for eGFR could serve as a novel screening tool for urothelial carcinoma. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.150701
Vancouver
Yamamoto A, Kawashima A, Sakai S, Mita M, Sassi N, Inoguchi S, et al. Serum D-asparagine concentration adjusted for eGFR could serve as a novel screening tool for urothelial carcinoma. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.150701
BibTeX
@article{Yamamoto2024,
author = {Yamamoto, Akinaru and Kawashima, Atsunari and Sakai, Shinsuke and Mita, Masashi and Sassi, Nesrine and Inoguchi, Shunsuke and Horibe, Yuki and Yoshimura, Akihiro and Tani, Masaru and Yutong, Liu and Okuda, Yohei and Oka, Toshiki and Uemura, Toshihiro and Yamamichi, Gaku and Ishizuya, Yu and Hayashi, Takuji and Yamamoto, Yoshiyuki and Kato, Taigo and Hatano, Koji and Kakuta, Yoichi and Imamura, Ryoichi and Takahara, Shiro and Kimura, Tomonori and Nonomura, Norio},
title = {Serum D-asparagine concentration adjusted for eGFR could serve as a novel screening tool for urothelial carcinoma},
journal = {Biochemical and Biophysical Research Communications},
year = {2024},
doi = {10.1016/j.bbrc.2024.150701}
}
EUVIMED